Blunting of the Heart Rate Response to Adenosine and Regadenoson in Relation to Hyperglycemia and the Metabolic Syndrome
To access this article, please choose from the options below
Dr. Iskandrian has received grant support from and provided consultant services to Astellas Pharma US, Inc., Deerfield, Illinois.
PII: S0002-9149(09)02768-4
doi:10.1016/j.amjcard.2009.11.042
© 2010 Elsevier Inc. All rights reserved.
